PUBLIC LAW 102-321—JULY 10, 1992 106 STAT. 363 Mental Health, and other appropriate institutes and shall consult with the Directors of such Institutes. "(b) DUTIES. —In carrying out the activities described in subsection (a), the Director of the Institute— "(1) shall collect and disseminate through publications and other appropriate means, information pertaining to the research and other activities under this section; "(2) shall make grants to or enter into contracts and coopera- Contracts, tive agreements with individuals and public and private entities to further the goals of the program; "(3) may, in accordance with section 496, and in consultation with the National Advisory Council on Drug Abuse, acquire, construct, improve, repair, operate, and maintain pharmacotherapeutic research centers, laboratories, and other necessary facilities and equipment, and such other real or personal property as the Director determines necessary, and may, in consultation with such Advisory Council, make grants for the construction or renovation of facilities to carry out the purposes of this section; "(4) may accept voluntary and uncompensated services; "(5) may accept gifts, or donations of services, money, or property, real, personal, or mixed, tangible or intangible; and "(6) shall take necessary action to ensure that all cheinnels for the dissemination and exchange of scientific knowledge and information are maintained between the Administration and the other scientific, medical, and biomedical disciplines and organizations nationally and internationaly. "(c) REPORT. — "(1) IN GENERAL. —Not later than December 31, 1992, and each December 31 thereafter, the Director of the Institute shall submit to the Office of National Drug Control Policy established under section 1002 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1501) a report, in accordance with paragraph (3), that describes the objectives and activities of the progrsim assisted under this section. "(2) NATIONAL DRUG CONTROL STRATEGY. —The Director of National Drug Control PoHcy shall incorporate, by reference or otherwise, each report suomitted under this subsection in the National Drug Control Strategy submitted the following February 1 under section 1005 of the Anti-Drug Abuse Act ofl988(21 U.S.C. 1504). "(d) DEFINITION. —For purposes of this section, the term 'pharmacotherapeutics'means medications used to treat the s>inptoms and disease of drug abuse, including medications to— "(1) block the effects of abused drugs; "(2) reduce the craving for abused drugs; "(3) moderate or eliminate withdrawars3m[iptoms; "(4) block or reverse the toxic effect of abused drugs; or "(5) prevent relapse in persons who have been detoxified from drugs of abuse. "(e) AUTHORIZATION OF APPROPRIATIONS.— For the purpose of carrying out this section, there are authorized to be appropriated $85,000,000 for fiscal year 1993, and $95,000,000 for fiscal year 1994.". (c) CONFORMING AMENDMENTS.— Section 515, 516, and 517 of the Public Health Service Act (42 U.S.C. 290cc) as such sections 42 USC 290cc, existed 1 day prior to the date of enactment of this Act are repealed. 290cc-l, 290cc-2.
�
